5-(2-Nitrophenyl)-1,3,4-thiadiazol-2-amine, 1g

3-(BOC-AMINOMETHYL)-BICYCLO[1.1.1]PENTANE-1-METHANOL, 95.0%, 250mg

(1S,3R)-3-(tert-Butoxycarbonylamino)cyclohexanecarboxylic Acid>97.0%(GC)(T)1g

3-bromo-5-iodopyridin-4-ol, 95.0%, 250mg

1-(2-ETHOXYETHYL)-2-(4-METHYL-1,4-DIAZEPAN-1-YL)-1H-BENZO[D]IMIDAZOLE, 95%, 25mg

3-Methoxy-4-methyl-2-nitrobenzoic acid, 95.0%, 250mg

Ethyl 4-(4-bromophenoxy)butanoate, 97%, 1g

1-[3,5-Bis(trifluoromethyl)phenyl]-3-[(1S,2S)-2-(pyrrolidin-1-yl)cyclohexyl]thiourea, 97%, 100mg

6-Bromo-3,4-dihydro-2H-pyrano[2,3-b]pyridine, 97%, 1g

4-BROMO-2-IODOBENZONITRILE, 98.0%, 10g

n-pentano, mínimo 99 %, para síntesis, 100 ml, envase de vidrio

Bromodifluoroacetic acid, 97.00%, 500g

3-Ethyl-1-methyl-1H-imidazol-3-ium Dimethyl Phosphate>98.0%(HPLC)(T)25g